Palvella Therapeutics (PVLA) Change in Receivables (2014 - 2025)
Palvella Therapeutics (PVLA) reported Change in Receivables of -$29000.0 for Q4 2025, up 91.9% on a QoQ basis from -$358000.0 in Q1 2025.
Palvella Therapeutics (PVLA) has 4 years of Change in Receivables data on file, last reported at -$29000.0 in Q4 2025.
- Quarterly Change in Receivables changed N/A year-over-year to -$29000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$387000.0 (changed N/A YoY) and the FY2025 annual result came in at -$387000.0, changed N/A from the prior year.
- Change in Receivables climbed to -$29000.0 in Q4 2025 per PVLA's latest filing, from -$358000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at -$29000.0 in Q4 2025 and bottomed at -$358000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Mar 31, 2025 | -358,000.00 |
| Mar 31, 2025 | -358,000.00 |
| Dec 31, 2017 | 12.13 Mn |
| Dec 31, 2017 | 12.13 Mn |
| Sep 30, 2017 | -44.15 Mn |
| Sep 30, 2017 | -44.15 Mn |
| Jun 30, 2017 | 46.50 Mn |
| Jun 30, 2017 | 46.50 Mn |
| Mar 31, 2017 | -19,328.00 |
| Mar 31, 2017 | -19,328.00 |
| Mar 31, 2016 | 68,870.00 |
| Mar 31, 2016 | 68,870.00 |
| Sep 30, 2014 | -474,418.00 |
| Sep 30, 2014 | -474,418.00 |
| Jun 30, 2014 | -68,553.00 |
| Jun 30, 2014 | -68,553.00 |
| Mar 31, 2014 | -479,677.00 |
| Mar 31, 2014 | -479,677.00 |